Dr. Norman Putzki, MD - Novartis - Gene Therapy And A New Era Of Neuroscience | Ira S. Pastor
Dr. Norman Putzki, MD - Novartis - Gene Therapy And A New Era Of …
30.6K views3 months ago
linkedin.com
FDA approves historic 'living drug' treatment to fight childhood leukemia
0:32
FDA approves historic 'living drug' treatment to fight childhood leuke…
Aug 30, 2017
latimes.comAssociated Press
Bringing gene therapy into focus
Bringing gene therapy into focus
Apr 8, 2019
novartis.com
Gene Therapy Manufacturing in North Carolina
Gene Therapy Manufacturing in North Carolina
Aug 14, 2022
novartis.com
How do cells learn to treat, prevent, or potentially even cure diseases?
How do cells learn to treat, prevent, or potentially even cure diseases?
Oct 6, 2020
vox.com
Novartis Radioligand Therapy Lutathera® Demonstrated Statistically Significant and Clinically Meaningful Progression-Free Survival in First Line Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Novartis Radioligand Therapy Lutathera® Demonstrated Statisti…
Sep 24, 2023
marketscreener.com
Postes vacants | Novartis France
Postes vacants | Novartis France
5 months ago
novartis.com
“Be bold.” Dr. Botond Roska, director of the Institute of Molecular and Clinical Ophthalmology explains why healthcare researchers should dare to address the impossible. | Novartis
0:38
“Be bold.” Dr. Botond Roska, director of the Institute of Molecul…
2.6K viewsNov 21, 2018
FacebookNovartis
Experimental gene therapy discovered in-house enters clinical testing
Experimental gene therapy discovered in-house enters clinic…
Mar 21, 2019
novartis.com
One breakthrough is never enough - we are committed to a relentless pursuit of cure. https://bit.ly/2Zs7008 #ReimagineMedicine #FightBloodCancer #BloodCancerAwarenessMonth | Novartis Cancer
0:28
One breakthrough is never enough - we are committed to a relentless p…
2K viewsSep 19, 2019
FacebookNovartis Cancer
Innovative Drugs Deserve Innovative Pricing
$
Innovative Drugs Deserve Innovative Pricing
Aug 31, 2017
FortuneDavid Agus,Dana Goldman,Bethany Cianciolo
Manufacturing CAR-T Cell Therapies: The Novartis Approach
Manufacturing CAR-T Cell Therapies: The Novartis Approach
6 months ago
novartis.com
Novartis Receives US FDA Breakthrough Therapy Designation for Ianalumab to Treat Sjogren's Disease
Novartis Receives US FDA Breakthrough Therapy Designatio…
2 months ago
marketscreener.com
Listening and acting to patients needs can save lives. Our Commitment is to include the patient perspective in the drug development process. Learn more about our Novartis Commitment to Patients and Caregivers. | Novartis
2:31
Listening and acting to patients needs can save lives. Our Commit…
199.5K viewsFeb 12, 2020
FacebookNovartis
Meet the makers and shakers of Novartis and take a media-rich deep-dive into the exhilarating universe of a modern medicines company: https://bit.ly/2XdqIJX | Novartis
0:30
Meet the makers and shakers of Novartis and take a media-rich de…
147.2K viewsJul 30, 2020
FacebookNovartis
Oncology Careers: Life Changing Purpose
Oncology Careers: Life Changing Purpose
Oct 7, 2019
novartis.com
Innovation and collaboration go hand in hand for our Immuno-Oncology researchers, as they seek to build smart drug combinations. | Novartis
0:20
Innovation and collaboration go hand in hand for our Immuno-Onc…
8.3K viewsJul 8, 2019
FacebookNovartis
Early diagnosis and therapy may help to delay MS progression, including cognitive changes. Spot the signs by asking simple questions. | Novartis
0:26
Early diagnosis and therapy may help to delay MS progression, incl…
213.2K viewsJun 5, 2019
FacebookNovartis
Novartis CEO talks about new cancer therapy programs
4:14
Novartis CEO talks about new cancer therapy programs
Jun 7, 2021
CNBC
We’re leveraging one of the strongest R&D engines in the world to reimagine medicine for patients. https://bit.ly/3CZVLM2 | Novartis
1:12
We’re leveraging one of the strongest R&D engines in the worl…
161.5K viewsNov 8, 2021
FacebookNovartis
Novartis Pharma AG: Novartis Kisqali 5-year NATALEE data demonstrate 28% reduction in risk of recurrence in the broadest early breast cancer patient population
Novartis Pharma AG: Novartis Kisqali 5-year NATALEE data dem…
4 months ago
finanznachrichten.de
FDA approves Novartis gene therapy for rare genetic disorder
0:47
FDA approves Novartis gene therapy for rare genetic disorder
May 24, 2019
CNBCMeg Tirrell
Since 2015, Novartis Access has worked to deliver treatments for chronic diseases in lower-income countries. Our two-year report takes an in-depth look at results, learnings and challenges on the ground so far. http://bit.ly/2HFldcK | Novartis
0:29
Since 2015, Novartis Access has worked to deliver treatments for c…
25.8K viewsMar 23, 2018
FacebookNovartis
Recommendation for Novartis May Give New Hope For Some Cancer Patients
Recommendation for Novartis May Give New Hope For Some Cancer …
Mar 7, 2024
thestreet.com
We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. | Novartis
0:23
We discover and develop breakthrough treatments and find …
727.8K viewsApr 9, 2019
FacebookNovartis
Novartis to release new gene therapy drug that could cost $2 million
2:33
Novartis to release new gene therapy drug that could cost $2 mi…
May 7, 2019
CNBCMeg Tirrell
Discover the science behind breakthrough CAR-T cell therapy
1:34
Discover the science behind breakthrough CAR-T cell therapy
Aug 19, 2018
Mail Online
Patients and caregivers know better than anyone what it means to live with a disease every day. By working with patient organizations, we systematically build patients’ perspectives into key decisions through a medicine’s life cycle. Six years ago, Novartis became the first Pharma company to publish a Commitment to Patients and Caregivers – our promise to embed the patient perspective in our journey to reimagine medicine. Every year, we publish our Factsheet to share our progress in numbers made
0:43
Patients and caregivers know better than anyone what it means to live …
3.7K viewsFeb 20, 2024
FacebookNovartis
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers
$
FDA Panel Backs Groundbreaking Novartis Treatment That Turns Yo…
Jul 12, 2017
FortuneSy Mukherjee
Novartis Pharma AG: Novartis receives FDA accelerated approval for Vanrafia (atrasentan), the first and only selective endothelin A receptor antagonist for proteinuria reduction in primary IgA nephropathy (IgAN)
Novartis Pharma AG: Novartis receives FDA accelerated approva…
Mar 4, 2025
finanznachrichten.de
See more